- Home
- NMTC vs PYPD Comparison
NMTC vs PYPD Comparison
Compare NMTC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- PYPD
- Stock Information
- Founded
- NMTC 2009
- PYPD 2008
- Country
- NMTC United States
- PYPD Israel
- Employees
- NMTC N/A
- PYPD N/A
- Industry
- NMTC Medical/Dental Instruments
- PYPD Medical/Dental Instruments
- Sector
- NMTC Health Care
- PYPD Health Care
- Exchange
- NMTC Nasdaq
- PYPD Nasdaq
- Market Cap
- NMTC 27.7M
- PYPD 24.1M
- IPO Year
- NMTC N/A
- PYPD 2020
- Fundamental
- Price
- NMTC $0.79
- PYPD $3.40
- Analyst Decision
- NMTC
- PYPD Strong Buy
- Analyst Count
- NMTC 0
- PYPD 2
- Target Price
- NMTC N/A
- PYPD $12.00
- AVG Volume (30 Days)
- NMTC 97.0K
- PYPD 7.6K
- Earning Date
- NMTC 12-12-2024
- PYPD 11-13-2024
- Dividend Yield
- NMTC N/A
- PYPD N/A
- EPS Growth
- NMTC N/A
- PYPD N/A
- EPS
- NMTC N/A
- PYPD N/A
- Revenue
- NMTC $3,922,499.00
- PYPD N/A
- Revenue This Year
- NMTC $109.53
- PYPD N/A
- Revenue Next Year
- NMTC $90.00
- PYPD N/A
- P/E Ratio
- NMTC N/A
- PYPD N/A
- Revenue Growth
- NMTC N/A
- PYPD N/A
- 52 Week Low
- NMTC $0.60
- PYPD $2.95
- 52 Week High
- NMTC $2.00
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- NMTC 41.71
- PYPD 48.44
- Support Level
- NMTC $0.83
- PYPD $3.33
- Resistance Level
- NMTC $0.94
- PYPD $3.58
- Average True Range (ATR)
- NMTC 0.07
- PYPD 0.25
- MACD
- NMTC -0.01
- PYPD 0.01
- Stochastic Oscillator
- NMTC 20.42
- PYPD 38.46
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.